Dr Reddys Laboratories (RDY) Total Non-Current Liabilities (2012 - 2026)

Dr Reddys Laboratories' Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $342.6 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities rose 16.67% year-over-year to $342.6 million; the TTM figure through Mar 2026 stood at $342.6 million (up 16.67% YoY), while the FY2026 annual figure was $334.0 million, up 12.08% from the prior year.
• Total Non-Current Liabilities was $342.6 million for Q1 2026 at Dr Reddys Laboratories, up from $332.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $342.6 million in Q1 2026 to a low of -$384.7 million in Q2 2023.
• Historically, Total Non-Current Liabilities has averaged $139.1 million across 5 years, with a median of $124.8 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities slumped 49.43% in 2022, then soared 177.01% in 2024.
• A 5-year view of Total Non-Current Liabilities shows it stood at $59.2 million in 2022, then surged by 99.37% to $118.0 million in 2023, then surged by 177.01% to $326.8 million in 2024, then rose by 1.72% to $332.4 million in 2025, then rose by 3.07% to $342.6 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $342.6 million (Q1 2026), $332.4 million (Q3 2025), and $293.7 million (Q1 2025), per Business Quant data.